These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 16841630)

  • 1. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
    Corya SA; Perlis RH; Keck PE; Lin DY; Case MG; Williamson DJ; Tohen MF
    J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.
    Keck PE; Corya SA; Altshuler LL; Ketter TA; McElroy SL; Case M; Briggs SD; Tohen M
    J Clin Psychiatry; 2005 May; 66(5):611-6. PubMed ID: 15889948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
    Brown EB; McElroy SL; Keck PE; Deldar A; Adams DH; Tohen M; Williamson DJ
    J Clin Psychiatry; 2006 Jul; 67(7):1025-33. PubMed ID: 16889444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.
    Thase ME; Corya SA; Osuntokun O; Case M; Henley DB; Sanger TM; Watson SB; Dubé S
    J Clin Psychiatry; 2007 Feb; 68(2):224-36. PubMed ID: 17335320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.
    Tohen M; Case M; Trivedi MH; Thase ME; Burke SJ; Durell TM
    J Clin Psychiatry; 2010 Apr; 71(4):451-62. PubMed ID: 20361905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.
    Brown E; Dunner DL; McElroy SL; Keck PE; Adams DH; Degenhardt E; Tohen M; Houston JP
    Int J Neuropsychopharmacol; 2009 Jul; 12(6):773-82. PubMed ID: 19079815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.
    Shelton RC; Williamson DJ; Corya SA; Sanger TM; Van Campen LE; Case M; Briggs SD; Tollefson GD
    J Clin Psychiatry; 2005 Oct; 66(10):1289-97. PubMed ID: 16259543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.
    Amsterdam JD; Shults J
    J Affect Disord; 2005 Jul; 87(1):121-30. PubMed ID: 15923042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
    Zanarini MC; Frankenburg FR; Parachini EA
    J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico.
    Tamayo JM; Sutton VK; Mattei MA; Diaz B; Jamal HH; Vieta E; Zarate CA; Fumero I; Tohen M
    J Clin Psychopharmacol; 2009 Aug; 29(4):358-61. PubMed ID: 19593175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study.
    Corya SA; Andersen SW; Detke HC; Kelly LS; Van Campen LE; Sanger TM; Williamson DJ; Dubé S
    J Clin Psychiatry; 2003 Nov; 64(11):1349-56. PubMed ID: 14658950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of depressive symptom improvement in bipolar I depressed patients.
    Williamson D; Brown E; Perlis RH; Ahl J; Baker RW; Tohen M
    J Affect Disord; 2006 Jun; 92(2-3):261-6. PubMed ID: 16563521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
    Corya SA; Williamson D; Sanger TM; Briggs SD; Case M; Tollefson G
    Depress Anxiety; 2006; 23(6):364-72. PubMed ID: 16710853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
    Detke HC; DelBello MP; Landry J; Usher RW
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.